|
Market Cap (25-Jun) $7,311,981 (1,468th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 582,113 |
Shortsold (6-Dec) 611,822 (0.21%) (374th) |
|
52w High $0.021 |
52w Low $0.009 |
P/E 11.60 |
EPS -0.01 |
ACR released this announcement to the ASX on 22 October 2021, 8:57. The announcement is not marked as price sensitive, and is 22 page(s) in length and 1.99MB in size.
You can view all announcements from ACR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACR was 0.004% short sold according to ASIC data. It was ranked the 605th most shorted stock on the ASX. It is now ranked as the 374th most shorted stock on the ASX with 0.210% of total shares short sold as of the latest reported data (06 December 2024).
| Other Recent Announcements from ACR | |
|---|---|
| Appendix 3Y Brooke | 16 June 2023, 9:27 |
| Application for quotation of securities - ACR | 16 June 2023, 9:25 |
| 4th FDA ANDA approval received - Dapsone Gel, 5% | 7 June 2023, 10:35 |
| Notice of Annual General Meeting/Proxy Form | 22 October 2021, 8:57 |
| Application for quotation of securities - ACR | 15 October 2021, 9:13 |
| Acrux and Harris terminate license agreement | 11 October 2021, 8:31 |
| Annual General meeting and date for director nominations | 27 September 2021, 9:36 |
You must be logged in to post a reply.
